Research
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1840 (Published 16 October 2008) Cite this as: BMJ 2008;337:a1840Related articles
- Editorial Published: 16 October 2008; BMJ 337 doi:10.1136/bmj.a1806
- Paper Published: 22 November 1997; BMJ 315 doi:10.1136/bmj.315.7119.1333
- Paper Published: 11 November 2000; BMJ 321 doi:10.1136/bmj.321.7270.1183
- Research Published: 06 November 2009; BMJ 339 doi:10.1136/bmj.b4531
- Letter Published: 19 November 2008; BMJ 337 doi:10.1136/bmj.a2583
- Research Published: 29 September 2015; BMJ 351 doi:10.1136/bmj.h4865
- Student Published: 10 August 2010; BMJ 341 doi:10.1136/sbmj.c4103
See more
- Diabetes UK defends partnership with Slimming World in face of criticismBMJ April 26, 2024, 385 q962; DOI: https://doi.org/10.1136/bmj.q962
- Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic testBMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744
- FDA approves first over-the-counter blood glucose monitor for diabetesBMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611
- US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDABMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes--2021
- Recommandations canadiennes pour les pratiques optimales de soins de lAVC, septieme edition : lacide acetylsalicylique pour la prevention devenements vasculaires
- Aspirin in Primary Prevention of Cardiovascular Events
- Aspirin for primary prevention of atherosclerotic cardiovascular events
- New treatments for peripheral artery disease
- Canadian Stroke Best Practice Recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events
- All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes--2020
- Population-based cross-sectional study of 11 645 Spanish nonagenarians with type 2 diabetes mellitus: cardiovascular profile, cardiovascular preventive therapies, achievement goals and sex differences
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal Cancer
- Aspirin for Primary Prevention of Cardiovascular Events
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes--2019
- Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial
- ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison
- How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial
- Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances
- 9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes--2018
- Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
- Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
- ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice
- A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative
- Response by Saito et al to Letter Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial"
- Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial
- 9. Cardiovascular Disease and Risk Management
- Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies
- Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations
- Vascular Complications of Diabetes
- Cardiovascular Disease in Women: Clinical Perspectives
- Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2{degrees}P-TIMI 50)
- 8. Cardiovascular Disease and Risk Management
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association
- Current management of diabetes mellitus and future directions in care
- Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
- Pharmacological Treatment and Current Management of Peripheral Artery Disease
- Frequency and Practice-Level Variation in Inappropriate Aspirin Use for the Primary Prevention of Cardiovascular Disease: Insights From the National Cardiovascular Disease Registrys Practice Innovation and Clinical Excellence Registry
- 8. Cardiovascular Disease and Risk Management
- Comparative Effectiveness Review of Antiplatelet Agents in Peripheral Artery Disease
- The Role of Aspirin in the Prevention of Cardiovascular Disease
- Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
- Aspirin Therapy in Primary Cardiovascular Disease Prevention: A Position Paper of the European Society of Cardiology Working Group on Thrombosis
- Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
- Standards of Medical Care in Diabetes--2014
- Effects of Changing Guidelines on Prescribing Aspirin for Primary Prevention of Cardiovascular Events
- Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register
- Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2{degrees}P-TIMI 50
- Medical Therapy in Peripheral Artery Disease
- Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
- Standards of Medical Care in Diabetes--2012
- 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
- American Diabetes Association Postgraduate Meetings--2011
- L'hypertension chez les diabetiques de type 2: Mise a jour sur le traitement pharmacologique
- Hypertension in people with type 2 diabetes: Update on pharmacologic management
- Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004
- Special considerations for treatment of type 2 diabetes mellitus in the elderly
- Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- Standards of Medical Care in Diabetes--2011
- Aspirin and the Prevention of Cardiovascular Disease in Chronic Kidney Disease: Time to Move Forward?
- Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index
- Type 2 diabetes and ASA
- Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation
- Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes
- Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
- Inclusion of Stroke as an Outcome and Risk Equivalent in Risk Scores for Primary and Secondary Prevention of Vascular Disease
- The Law of Diminishing Returns in Clinical Medicine: How Much Risk Reduction is Enough?
- Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
- Inflammation and the Osteogenic Regulation of Vascular Calcification: A Review and Perspective
- Aspirin for primary prevention of cardiovascular disease?
- Standards of Medical Care in Diabetes--2010
- Aspirin for the Primary Prevention of Cardiovascular Events: A systematic review and meta-analysis comparing patients with and without diabetes
- The Ankle-Brachial Index as a Biomarker of Cardiovascular Risk: It's Not Just About the Legs
- Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
- Aspirin for primary prevention of cardiovascular disease?
- Effective platelet inhibition by aspirin and clopidogrel: where are we now?
- Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
- The Role of Diabetes Educators in the Medical Home
- Diabetes Quality Improvement: Rigor and Ridicule
- Antiplatelet agents
- Don't stop taking aspirin
- Time for a proper study of aspirin after a vascular event?
- No Benefit for Aspirin in Diabetic Patients Without Symptomatic CVD
- Aspirin or Antioxidants for Primary Prevention? Not so Fast!